Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $1.76 Million - $2.05 Million
18,247 Added 102.41%
36,065 $3.71 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $1.7 Million - $1.8 Million
15,870 Added 814.68%
17,818 $1.94 Billion
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $4.56 Million - $8.31 Million
-73,041 Reduced 97.4%
1,948 $222 Million
Q2 2022

Aug 12, 2022

BUY
$79.4 - $116.36 $5.95 Million - $8.73 Million
74,989 New
74,989 $5.98 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.